RCMD-MSCs demonstrated low CD73 and high CD105 expression frequencies with variations in the expression levels (101–104 intensity units) compared to the control MSCs and MSCs of other MDS subtypes. The gene discussed is NT5E; the disease is myelodysplastic syndrome with multilineage dysplasia.